HGH 176–191 5 mg

HGH 176–191 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, consisting of amino acids 176 through 191. This fragment is studied independently from full-length hGH to explore domain-specific biological activity, particularly in relation to adipocyte metabolism and glucose-related cellular pathways.

Research interest in HGH 176–191 focuses on its role in experimental models of lipid handling, glucose transport, and metabolic signaling. By isolating this specific region of the growth hormone molecule, researchers investigate how discrete peptide domains may contribute to metabolic regulation without invoking the full endocrine profile of intact hGH.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

HGH Fragment 176-191 represents the C-terminal region of human growth hormone and retains the lipolytic activity associated with the full-length molecule without its growth-promoting or insulin-desensitizing effects. Research has focused on its activation of beta-3 adrenergic receptors and its role in stimulating fat oxidation in adipocytes. Studies have explored its potential in metabolic and obesity-related research models (Ng et al., 1990 — Journal of Molecular Endocrinology).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling. Store at -20°C. See also: IGF-1 LR3 1 mg, Ipamorelin 10 mg, Tesamorelin 10 mg